-
<![CDATA[Breast Cancer Experts: Key ADC Developments and CDK 4/6 Inhibitor Updates Set to Dominate ESMO 2025]]>
25 Sep 2025 16:11 GMT
… carboplatin, nab-paclitaxel, or paclitaxel] plus pembrolizumab in … positive, endocrine-refractory breast cancer setting, where patients … HR-positive metastatic breast cancer cases without PIK3CA … triple negative breast cancer
315P - SYNERGIA breast cancer - …
-
Clinical Management of Circulating Tumor DNA in Breast Cancer: Detection, Prediction, and Monitoring
25 Sep 2025 14:07 GMT
… stage breast cancer and 50 individuals with benign breast tumors … 030, evaluating neoadjuvant paclitaxel plus cisplatin and residual … patients with early breast cancers. ESMO Open. … biomarkers in breast cancer. clin breast cancer. Clin Breast Cancer. 2022;22 …
-
Enhertu plus pertuzumab granted Priority Review in US as 1st-line treatment for patients with HER2-positive metastatic breast cancer
25 Sep 2025 03:31 GMT
… taxane [docetaxel or paclitaxel], trastuzumab and pertuzumab) … the biologically diverse breast cancer tumour environment.
With … new breast cancer settings.
In HR-positive breast cancer, … negative breast cancer, an aggressive form of breast cancer, AstraZeneca …
-
<![CDATA[Dr Tolaney on the Potential Role for Sac-TMT With/Without Pembrolizumab in HR+, HER2– Breast Cancer ]]>
23 Sep 2025 03:50 GMT
… or locally advanced metastatic breast cancer.
Sac-TMT is … positive, HER2-negative breast cancer who have not been … chemotherapy, which comprises paclitaxel plus nab-paclitaxel, capecitabine, or … or locally advanced metastatic breast cancer. Currently, the only …
-
<![CDATA[New T-DXd Data Have the Potential to Reorder ADC Sequencing in HER2+ Breast Cancer]]>
22 Sep 2025 13:20 GMT
… of care (SOC) paclitaxel or docetaxel plus trastuzumab … positive breast cancer and other clinical questions in breast cancer such … or metastatic HER2-positive breast cancer. FDA. December 20 … -trastuzumab-emtansine-early-breast-cancer
Trastuzumab emtansine(T- …
-
Biostar Pharma’s Utidelone Receives Third Orphan Drug Designation from FDA for Pancreatic Cancer
26 Sep 2025 19:32 GMT
… Utidelone, following earlier designations for breast cancer brain metastases and gastric cancer … activity compared to the conventional paclitaxel and gemcitabine treatment.
At the …
-
The FDA Granted Orphan Drug Designation to Biostar Pharma’s Utidelone for the Treatment of Pancreatic Cancer
25 Sep 2025 16:48 GMT
… FDA, following prior designations for breast cancer brain metastases and gastric cancer … activity compared with the traditional paclitaxel plus gemcitabine regimen. At the … for the treatment of metastatic breast cancer (MBC), who have progressed after …
-
<![CDATA[FDA Grants Utidelone Injection Orphan Drug Designation for Pancreatic Cancer]]>
25 Sep 2025 16:11 GMT
… treatment of patients with breast cancer brain metastases and … the traditional combination of paclitaxel and gemcitabine as … for the treatment of breast cancer brain metastases. News release … for-the-treatment-of-breast-cancer-brain-metastasis-302103497.html …
-
Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine Applications
25 Sep 2025 14:07 GMT
… efficacy of paclitaxel in triple-negative breast cancer cells. … were developed for breast cancer treatment. These nanoparticles … nanoparticles for targeting breast cancer metabolism. Polymers. … breast cancer but not HER2/neu-positive breast cancer. …
-
Metastatic Brain Adenocarcinoma and Pelvic Squamous Carcinoma Originating From Cervical Adenosquamous Carcinoma: A Case Report and Literature Review
25 Sep 2025 08:22 GMT
… cancer burden, only after breast cancer. In 2021, the … , 2018, she received 【paclitaxel + cisplatin】chemotherapy for 1 … intravenous chemotherapy combined with immunotherapy【Paclitaxel for Injection (Albumin Bound … lung, colon and breast cancer in women, CC has …